Safety Assessment of Influenza Vaccination for Neurological Outcomes Among Older Adults in Japan: A Self‐Controlled Case Series Study
We found no evidence that the risk of adverse neurological events was increased after influenza vaccination in older adults. These results may help reassure older adults who are hesitant to receive influenza vaccination because of concerns regarding adverse neurological outcomes.
Authors
- Yoshinori Takeuchi (ORCID: https://orcid.org/0000-0001-9821-0513)
- Kohei Uemura
- Nobuaki Michihata (ORCID: https://orcid.org/0000-0003-3091-114X)
- Yuichiro Iida (ORCID: https://orcid.org/0000-0001-5062-3255)
- Mitsunori Ogawa (ORCID: https://orcid.org/0000-0002-7671-7396)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Masao Iwagami (ORCID: https://orcid.org/0000-0001-7079-0640)
- Daisuke Koide (ORCID: https://orcid.org/0000-0002-4238-0334)
- Sachiko Ono (ORCID: https://orcid.org/0000-0003-4378-2578)
- Yutaka Matsuyama (ORCID: https://orcid.org/0000-0003-2009-6831)
Institutions
- Tokyo University of Information Sciences (JP)
- University of Tsukuba (JP)
- Okayama University Hospital (JP)
- Chiba Cancer Center (JP)
- The University of Tokyo (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1002/pds.70082
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Japan Agency for Medical Research and Development